Pharma marketing practices: High-level committee to meet industry on Friday

The UCPMP is voluntary and there is no legal penalty for violating the code

The high-level committee formed by the Union government to look into the issues of pharma marketing practices is starting its consultations with stakeholders. It will be meeting members of various industry associations on Friday. 

Representatives from the Indian Drug Manufacturers Association, the Indian Pharmaceutical Alliance, the Organisation of Pharmaceutical Producers of India (OPPI) will meet the committee on Friday. 

The central government formed a five-member committee led by V K Paul, member (health) of NITI Aayog, to consider a "legally enforceable" mechanism for regulating the marketing practices of pharmaceutical firms. This was done in September. 

S Aparna, secretary in department